← All forecasts · November 2–6

PH / FQ1 2027 (quarter ended 2026-09-30)

Parker-Hannifin Corporation

Reported: Nov 5, 2026

Forecast published

Opus 5.5 High in Shortcut

Review incomplete

Shortcut

8.37

Normalized diluted EPS

+2.4% vs Street

Off by $0.53 per share

Street

8.17

Normalized diluted EPS

November 1 consensus snapshot

Off by $0.73 per share

Real

8.90

Reported normalized EPS

Shortcut win

Reported result · Nov 5 ↗ · Provider normalized EPS matches issuer adjusted EPS of $8.90 for fiscal Q1 2027; GAAP EPS is $6.92.

USD per diluted ordinary/common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.

Shortcut’s reasoning.

Q1 FY27 guide (6-Aug-26): adjusted EPS ~$8.07, ~9% reported / ~8% organic sales growth, 27.7% adj. segment margin, excluding Filtration Group (FGC). Frozen consensus $8.17 sits only ~$0.10 above guide - the same set-up as each of the last 4 quarters, when Parker beat its own guide by $0.42-1.11.

Filtration Group closed 13-Aug-26: ~$274m of sales in the quarter (pro-rata of the ~$1.8bn 10.5-month contribution), ~60/40 NA/International; issuer says neutral to Q1 adjusted EPS - modelled FGC segment income (~$59m) roughly offsets ~$57m of incremental interest.

Organic growth 8.5% (NA 8.0%, Intl 7.5%, Aero 10.5%) vs ~8% guide: rolling-12 orders +12% and record $12.8bn backlog at Jun-26, ISM PMI 54.5 in Sep-26, Dover +7.1% organic, GE Aerospace revenue +18% and Howmet commercial aero +32% in the Sep-26 quarter (Honeywell Aerospace +2% is the negative read-across).

Legacy adjusted segment margin ~28.1% vs 27.7% guide (Parker beat its quarterly margin guide in 3 of the last 4 quarters); corporate G&A $50m, adjusted other expense $55m (Q1 seasonally high), interest $142m, 22.5% tax, 127.7m diluted shares -> $8.37 adjusted EPS (+2.5% vs consensus), not inflated by beat rate.

GAAP EPS $6.79 is below the $7.10 guide because FGC amortization (~$36m), FGC integration/step-up and transaction costs (~$65m) are new adjustments not in guidance.

On the record.

Reporting period
FQ1 2027 (quarter ended 2026-09-30)
Reporting basis
Adjusted (non-GAAP) diluted EPS per common share, USD = normalized EPS basis
Consensus snapshot
November 1, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Original workbook · review incomplete
Record history
Forecast generated
Nov 1, 2026 at 10:52 PM PST
First posted
Nov 2, 2026 at 4:10 PM PST
Result checked
Nov 6, 2026 at 1:55 AM PST
Result basis

Provider normalized EPS matches issuer adjusted EPS of $8.90 for fiscal Q1 2027; GAAP EPS is $6.92. All six frozen normalized historical EPS values match.